Attention Deficit Hyperactivity Disorder Adhd clinical trials

Explore recruiting attention deficit hyperactivity disorder adhd clinical trials.

Recruiting attention deficit hyperactivity disorder adhd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Attention Deficit Hyperactivity Disorder Adhd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 4, Multicenter, 2-part Study Composed of a Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation followed by a Open-label Evaluation to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged-release (SPD503) in Children and Adolescents aged 6 to 17 Years with Attention-deficit/Hyperactivity Disorder

Sweden, Netherlands, Spain, Belgium, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Microdosing with a serotonergic agent for ADHD and emotion regulation: biological factors explaining and predicting treatment response

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

EEG-MRI Study of the Effect of Methylphenidate on Neural Mechanisms in Adult Patients With ADHD With or Without Mood Disorders: a Randomized Controlled Trial Versus Placebo

France

Phase II and Phase III (Integrated) EU CTIS Study details

Attention Deficit Hyperactivity Disorder Adhd trials by city

Attention Deficit Hyperactivity Disorder Adhd in Toronto Attention Deficit Hyperactivity Disorder Adhd in Vancouver Attention Deficit Hyperactivity Disorder Adhd in Montreal Attention Deficit Hyperactivity Disorder Adhd in Calgary Attention Deficit Hyperactivity Disorder Adhd in Edmonton Attention Deficit Hyperactivity Disorder Adhd in Ottawa Attention Deficit Hyperactivity Disorder Adhd in Winnipeg Attention Deficit Hyperactivity Disorder Adhd in Quebec City Attention Deficit Hyperactivity Disorder Adhd in Hamilton Attention Deficit Hyperactivity Disorder Adhd in Kitchener Attention Deficit Hyperactivity Disorder Adhd in London Attention Deficit Hyperactivity Disorder Adhd in Halifax Attention Deficit Hyperactivity Disorder Adhd in New York Attention Deficit Hyperactivity Disorder Adhd in Los Angeles Attention Deficit Hyperactivity Disorder Adhd in Chicago Attention Deficit Hyperactivity Disorder Adhd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease